LBN 764 is a type of chemical compound known as a small molecule inhibitor. It is primarily studied for its potential therapeutic effects in treating various diseases, particularly in the field of oncology. Researchers are investigating its ability to target specific pathways involved in cancer cell growth and survival. The compound is part of a broader category of drugs that aim to disrupt the mechanisms that allow tumors to thrive. Ongoing studies are focused on understanding its efficacy, safety, and the best ways to integrate it into existing treatment regimens for patients with specific types of cancer.